A further difference to castration, and a notable benefit of ERβ activation, is the ability to induce apoptosis in normal prostatic basal cells, human prostate cancer xenografts and castrate-resistant prostate cancer cell lines [8]. The gene discussed is ESR2; the disease is prostate carcinoma.